Abstract
We generate a mouse model for the human microcephaly syndrome by mutating the ASPM locus, and demonstrate a premature exhaustion of the neuronal progenitor pool due to dysfunctional self-renewal processes. Earlier studies have linked ASPM mutant progenitor excessive cell cycle exit to a mitotic orientation defect. Here, we demonstrate a mitotic orientation-independent effect of ASPM on cell cycle duration. We pinpoint the cell fate-determining factor to the length of time spent in early G1 before traversing the restriction point. Characterization of the molecular mechanism reveals an interaction between ASPM and the Cdk2/Cyclin E complex, regulating the Cyclin activity by modulating its ubiquitination, phosphorylation and localization into the nucleus, before the cell is fated to transverse the restriction point. Thus, we reveal a novel function of ASPM in mediating the tightly coordinated Ubiquitin- Cyclin E- Retinoblastoma- E2F bistable-signalling pathway controlling restriction point progression and stem cell maintenance.
Maintenance of stem cell populations employs intricate diverse mechanisms committed to balance cell division and differentiation by utilizing intrinsic and extrinsic regulatory factors. Understanding the mechanisms that promote stem cell maintenance should offer new opportunities to counter degenerative diseases and to use these cells for therapeutic purposes. An informative strategy is to detect genes that play central roles in pathways that regulate the maintenance and self-renewal of stem cells. The current study describes a newly generated mouse model for the human microcephaly syndrome1,2 targeted at the ASPM gene. It establishes that an overall reduced brain size of ASPM mutant mice with distinct radial thinning of the cortical wall was due to premature exhaustion of the neural progenitor cell (NPC) reservoir owing to dysfunctional self-renewing divisions.
Molecular mechanisms have evolved to regulate embryonic NPC expansion ensuring the maintenance of sufficient progenitors to meet the exponential demand for subsequent born neurons3,4. It has been suggested that the ASPM gene has undergone positive selection during hominid development that instigated the dramatic evolutionary increase in cortical neurons1,5,6. The ASPM localization to the minus ends of central spindle microtubules, centrosomes and spindle poles has been central to its functional analyses7,8. In response to external pulling forces, ASPM, complexed with LIN-5 and calmodulin at the poles, directs spindle alignment according to cues from the cell subcortex9. Mice in which ASPM is downregulated showed abnormal cleavage plane orientation of mitotic NPC10 and a concurrent decline in symmetric progenitor divisions. However, it is controversial whether cleavage plane angle is the primary determinant mediating mammalian progenitor/stem cell divisions3. Mice mutant for the polarity determinant aPKCλ exhibited impeded mitotic cell divisions due to disrupted apical adherens junctions. Yet, corticogenesis and brain size were normal11. Depletion of LGN, a non-centrosomal determinant of spindle orientation, caused randomized cell division and apical progenitor displacement. Nevertheless, progenitor pool and cortex development were intact12. Recent data have shown that mouse and primate mitotic spindle size asymmetry is a key component of asymmetric cell division in the cerebral cortex13 independently of spindle orientation14. Despite that, abnormal cleavage orientation remains the exclusive explanation for the declines in symmetric progenitor divisions in ASPM downregulated mice10 .
The widely accepted G1-phase length hypothesis3,15–17 uses the progressive lengthening of the G1-phase from 3 to 12 h in the mouse cortex18 to address the apparent inconsistency between an increasing frequency of NPC undergoing neurogenic-differentiative divisions despite steady state proportions of tilted dividing NPC during corticogenesis. The premise of the hypothesis is that regardless of division orientation, if the G1-phase is sufficiently long for the cell to receive and process intrinsic or extrinsic differentiative signals, then the daughter cells will exit the cell cycle (CC). Its support comes from studies that triggered premature neurogenic divisions by artificially lengthening NPC-CC19–21. Conversely, forced shortening of the NPC-CC promoted symmetric proliferative cell divisions21–24. G1 is considered to be a critical period during which cells decide whether to progress to S-phase, enter quiescence or differentiate. In fact, it has been proposed that G1 shortening shields pluripotent ES cells from differentiation inducing cues. ES cell insensitivity to differentiating signals due to a brief G1 is a result of excessive levels of constitutively active Cyclin E/Cdk2 complex resulting in hyperphosphorylation of retinoblastoma (RB)25,26. As development proceeds, multipotent stem cells go through a lengthening of G1, which permits increased checkpoints and cell extrinsic regulation.
In addition to mitotic orientation dependence, a novel mechanism by which ASPM regulates NPC division is presented here. By interaction with Cyclin E/Cdk2, ASPM controls Cyclin E abundance through regulating its ubiquitin-dependent proteolysis. Shown here is that the ASPM – Ubiquitin – Cyclin E – RB – E2F pathway regulates numerous aspects of NPC-CC progression, including mitosis duration and passage through the G1 restriction point. Exogenous Cyclin E or proteasome inhibitor administered to the developing ASPM null cortex rescue its NPC aberrant CC timing and fate determination, but not the abnormal mitotic cleavage orientation, providing conclusive evidence linking the mode of progenitor division to the time residing within the early part of G1.
Results
Microcephalic characteristics of ASPM mutant mice
To investigate the role of ASPM in brain development, an ASPM truncating mutation was fashioned by insertion of an ires-cre-neo cassette (Supplementary Fig. 1a). Northern and western blotting analyses (Supplementary Fig. 1b) confirmed the predicted truncation of ASPM mRNA and protein in homozygous mutant mice (henceforth referred to as ASPMΔ). ASPMΔ mice are viable, born in Mendelian ratios and show a fully penetrant 20% smaller wet brain weight as embryo, continuing throughout life with a particular reduction in cortical dimension (Fig. 1a–c and Supplementary Fig. 1c–g)8. ASPMΔ adults are similar in body weight to WT and heterozygous littermates (Fig. 1d) therefore they maintain abnormally low brain-to-body weight ratios, which is a hallmark of the microcephalic phenotype in humans.
Premature exhaustion of cortical ASPMΔ NPC pool
Histological analysis of adult ASPMΔ brains showed distinct thinning of the cortex that stems from a pronounced reduction of the superficial, later born layers II–IV (Fig. 1e,f). The substantial decrease in superficial layers corresponded to an increase in older and deeper layer VI cells (Fig. 1f). Although ASPM is predominantly expressed in the proliferating ventricular and subventricular zones (VZ and SVZ) along the four ventricles of the embryonic CNS1,8 (Supplementary Fig. 1h), the cortical irregularities evolved in the absence of apparent alterations of VZ/SVZ growth fraction (GF), cell death and neural migration (Supplementary Figs 1i – k and 2a).
The expanded deep layer and reduced superficial layers point to premature increase in cell output at the expense of the proliferative pool and subsequent later born neuron production. Accordingly, Fig. 1g evidences a sharper progressive reduction of the ASPMΔ NPC compartment at mid-to-late corticogenesis (Supplementary Fig. 2b), and Fig. 1h substantiates premature withdrawal of cells due to increased probability of VZ-NPC cell-cycle exit (Quiescence fraction) at the expense of the proportion of daughter cells that re-enter the cell cycle (Proliferative fraction)18. Thus, ASPM is required to facilitate NPC advance into S-phase rather than exiting from active CC, and its deficiency results in abnormally increased kinetics of the P to Q shift.
Irregular neurogenic to proliferative division ratio
In accordance with previous observations reported from knock down experiments10, ASPM truncation caused a shift towards horizontal and oblique mitotic cleavage planes with a consequent considerable decrease in the proportion of basal mitoses with apicobasal cleavage planes (Fig. 1i). Although horizontal cleavage planes typically generate asymmetric cell fates, with one P daughter cell and a Q neuron27–29, irregular cleavage orientation of ASPMΔ basal mitoses is neither sufficient to explain the generation of excessive neural progeny (Fig. 1h), nor the accelerated depletion of the progenitor pool (Fig. 1g). As illustrated in Fig. 1i, throughout both WT and ASPMΔ corticogenesis, proportions are maintained overtime but differ between genotypes. Therefore, the progressively increasing Q fraction reported here (Fig. 1h) and by others18,29 requires an additional mechanism unrelated to cleavage plane orientation for mediating asymmetric and symmetric divisions. For this reason, ASPM’s role in cell fate decisions was examined in clonal pair-cell assay. Scoring the fate of a single precursor’s first division following isolation from the embryonic cortex revealed that ASPMΔ NPC carried out significantly more P-N asymmetric-neurogenic divisions in young E12.5 embryos, and more N-N symmetric-neurogenic divisions in older E14.5 embryos, always at the expense of P-P symmetric-proliferative divisions (Fig. 1j and Supplementary Fig. 2c). Hence, ASPM is necessary to maintain symmetric P-P proliferative divisions of NPC even in the absence of a specific structural niche.
Impaired cell cycle of ASPMΔ NPC
During typical corticogenesis, the progressive increase in neuron production (Q) (Fig. 1h) and frequency of neurogenic divisions (P-N and N-N) (Fig. 1j) coincides with a progressive lengthening of the CC, mainly due to a slow down of the G1-phase18. In fact, converging observations suggested a link between CC kinetics and the mode of NPC division15,16,19–22,30,31 (Supplementary Fig. 3). Correspondingly, three distinct analyses pointed to impaired CC progression of ASPMΔ cortical NPC. First, similar to previously reported ASPM siRNA knockdown experiments32,33, in response to growth factors the average clonal size of E14.5 telencephalic derived ASPMΔ neurospheres was significantly smaller (Fig. 2a), indicting an impaired capacity to respond to proliferative signals. Also, secondary and tertiary neurosphere formation (from single dissociated primary and secondary spheres) showed significant impairment in ASPMΔ NPC self-renewal capacity (Fig. 2b). To reinforce the in vitro observation, an in vivo display of impaired CC was provided by analysis of the neurogenetic interval duration. Figure 2c shows singly BrdU labelled (at E16) matching P4 coronal cortical planes in which the cortical termination wave front of ASPMΔ mutant appeared laterally displaced (arrows). Since the initiation and termination ‘wave fronts’ of neural production advances along the rostrolateral to caudomedial axis of the cortical hemisphere34, monitoring the transverse neurogenetic termination gradient allows comparison of neurogenetic interval durations between developing cortices. Accordingly, the laterally displaced ASPMΔ termination wave front indicates an extended corticogenesis. Lastly, ASPMΔ NPC exhibited delayed succession of an internal clockwise developmental sequence, shown by tracking the expression and cellular localization of the Cux1 and Brn1 transcription factors (Supplementary Fig. 4).
To precisely measure in vivo CC duration, two assays were employed; double IdU/BrdU labelling procedure (Supplementary Fig. 5) and cumulative labelling index (LI) approach (Supplementary Fig. 6). The measurements revealed that overall CC length (TC) was significantly longer in both ASPMΔ VZ-NPC (Fig. 2d and Supplementary Tables 1 and 2) and in ASPMΔ SVZ progenitors (Fig. 2e). Surprisingly, neither FACS analyses nor Ki67 staining highlighted any particular phase contributing disproportionately to the considerably lengthened TC (Supplementary Fig. 7), suggesting that all CC phases are comparatively extended in ASPMΔ germinal layers. Accordingly, the double IdU/BrdU labelling and cumulative LI techniques proved that duration of S-phase (TS) in both germinal layers were significantly longer in ASPMΔ NPC (Fig. 2d,e). Next, the combined length of G2 – and M-phases (TG2 + M) was determined by monitoring the percentage of labelled mitoses demonstrating that TG2 + M of mutant NPC was invariantly 1.5 h longer in both germinal layers (Supplementary Fig. 8 and Supplementary Tables 3 and 4).
On the other hand, initial ASPMΔ G1-phase duration was not significantly longer. Only at E16.5 did the trend become significant in both VZ – and SVZ-NPC (Fig. 2e,f and Supplementary Table 2). This result departs unexpectedly from the widely accepted relationship between G1 duration and the mode of NPC division15, as ASPMΔ NPC displayed increased neurogenic divisions earlier then E16.5 (Fig. 1h,j). Therefore, kinetics of G1 during early corticogenesis were further explored, particularly the passage through restriction (R)-point from mitogen-dependent early to mitogen-independent late G1-phases 35. Timing the passage through the R-point along the G0 to S-phase interval of cultured synchronized NPC (Supplementary Fig. 9a) revealed that the early G1 of ASPMΔ NPC was 7.5 h longer (Fig. 2g). Notably, the defect in R-point regulation did not account to an overall increase in G1 duration, since kinetics of S phase entries (Supplementary Fig. 9b) were nearly identical between ASPMΔ and WT (Fig. 2h). Thus, the passage from the intrinsic and extrinsic signal-dependent early G1 to mitogen-independent late G1 is inefficient in ASPMΔ NPC.
Delayed Cyclin E accumulation and sequential phosphorylation
To understand the molecular mechanism underlying the ASPM regulation of R-point transition, protein levels of the transition main regulators were compared between ASPMΔ and WT NPC. ASPMΔ NPC displayed normal levels of Cdk2 and relatively similar levels and expression pattern of the early G1 regulator Cyclin D1 (Fig. 3a and Supplementary Fig. 10a). On the other hand, levels of the late G1 regulator, Cyclin E, were significantly downregulated in ASPMΔ NPC (Fig. 3b) corresponding with decreased activity of the Cyclin E/Cdk2 complex (Fig. 3c). Equal Cyclin D1 kinase activity between ASPMΔ and WT NPC reflected the comparable Cyclin D1 protein levels (Fig. 3a,c). Moreover, unchanged Cyclin D1 kinase activity proved that the increased p27 levels (Fig. 3a) did not inhibit Cyclin D1/Cdk(4/6) activity in ASPMΔ NPC. For comprehensive discussion into ASPM indirect regulation of p27 levels see Supplementary Fig. 10.
The reduced ASPMΔ Cyclin E detected by western blotting was further established by IHC. In particular, proportions of NPC positive for Cyclin E phosphorylated on residue T62 were significantly reduced (Fig. 3d,i) in both G1 – and S – phase cells (Fig. 3e,f). Proportions of P-Cyclin ET380 were slightly decreased, especially in ASPMΔ G1 cells (Fig. 3d–f). Although western blotting depicted reduced level of overall Cyclin E (pan-CycE) (Fig. 3b), the largest part of NPC were positive for pan-Cyclin E by IHC (Fig. 3i), indicating reduced amount of Cyclin E per cell. This is in line with the significant reduced intensity of staining with anti P-Cyclin ET62 and anti P-Cyclin ET380 Abs, measured in G1 – but not in S-phase NPC (Fig. 3g,h). Cyclin E in complex with Cdk2 was shown to localize to the nucleus36 only once beyond the R-point37,38. Figures 3d,i show that it is the P-Cyclin ET62 that was mainly localizes to the nucleus of G1 cells. S-phase cells, on the other hand, exhibited nuclear Cyclin E of both phosphorylated forms (Fig. 3d). Thus, as accumulation of Cyclin E and activity of the Cyclin E/Cdk2 complex reach maximum in late G1 and are essential for passage through the R-point and S-phase entry39, the significantly decreased P-Cyclin ET62 in nuclei of ASPMΔ NPC in G1 further signifies postponed passage through the R-point threshold.
Detailed analysis of the IHC shown in Fig. 3d–f suggests a sequential phosphorylation of Cyclin E as NPC progress from G1 to S. Starting at mid G1, Cyclin E is mainly phosphorylated on residue T62 before acquiring further phosphorylation on residue T380 at late G1. To support these intriguing observations, in vitro assay was performed on freshly isolated synchronized NPC (Supplementary Fig. 12a). At early G1 (3 h), most Cyclin E+ WT-NPC were P-Cyclin ET62+ while only 50% were positive for P-Cyclin ET380 (Fig. 3j,m left panels, Supplementary Fig. 12b). Past the R-point (13 h), all WT-NPC were P-Cyclin ET62+. Subsequently, cells became P-Cyclin ET380+ in S-phase (26 h) (Fig. 3j,k, Supplementary Fig. 12b). Notably, comparison between WT and ASPMΔ in vitro cultured NPC showed striking resemblance to the in vivo results, that is, a significant decrease in G1 – and S – T62 phosphorylation, and a slight decrease in G1 – T380 phosphorylation (Fig. 3l,m). Furthermore, in vivo and in vitro IHC using pan-CycE Abs exhibited mostly cytoplasmic localization in G1, and dual nuclear and cytoplasmic localization in S (Fig. 3i, Supplementary Fig. 12b). Mutant Cyclin E that cannot bind to Cdk2 was shown to localized to the cytoplasm40, suggesting that non-phosphorylated Cyclin E in G1 is Cdk2-unbound. Altogether, in vivo and in vitro assessments of Cyclin E levels as NPC proceed from G1 to S, established a crucial ASPM function. Tracking the extent of phosphorylation pinpointed to ASPM regulation of phosphorylated Cyclin E levels, particularly on residue T62, in concert with coordinated passage through the R-point.
Aberrant RB-E2F activity along the G1 to S interval
In accord with changes in kinase activity (Fig. 3c), pRBT821 phosphorylated by the Cyclin E/Cdk2 complex41 was significantly decreased in ASPMΔ NPC (Fig. 4a – c). A related increased levels of pRBS780, phosphorylated by Cyclin D/Cdk(4/6), were detected (Fig. 4a). Particularly significant reduced pRBT821 phosphorylation was observed in ASPMΔ S-phase NPC (Fig. 4d). Predicted from the pattern of RB phosphorylation, ASPMΔ NPC displayed significantly reduced endogenous E2F activity (Fig. 4e), as well as changes in the relative expression of several E2F target genes (Supplementary Fig. 13).
Cyclin E- dependent and independent ASPM function
To address whether ASPM regulation of CC timing, mitotic cleavage orientation, and fate determination are Cyclin E dependent, E14.5 embryos were transduced in utero with lentivirus harbouring Cyclin E in frame with F2A-mCFP or control mCFP (Fig. 5a). Western blot analyses and strong blue fluorescence along the entire cortical wall indicate continuous strong Cyclin E expression (Fig. 5b,c). Essentially, ASPMΔ transduced cortices were phenotypically rescued. For the most part, lentiviral-Cyclin E transduction resulted in a complete rescue of late G1 nuclear P-Cyclin ET62 distribution (Fig. 5c). Though lentiviral-Cyclin E transduction produced only 10% rescue of whole brain weight (Fig. 5d) (ASPMΔ + mCFP 62.00 ± 0.45 mg; + CycE 68.38 ± 0.88 mg, n = 5, P = 0.0002 by Student’s t-test), it resulted in a nearly full recovery of the telencephalic vesicle dimensions (Fig. 5e,f) (ASPMΔ + mCFP 4.12 ± 0.028 mm; + CycE 4.35 ± 0.024 mm, n = 4, P = 0.0005 by Student’s t-test, WT + mCFP 4.37 ± 0.121 mm; + CycE 4.65 ± 0.164 mm, n = 6, not significant by Student’s t-test).
Restoring adequate levels of Cyclin E into ASPMΔ telencephalic NPC completely corrected their prolonged TC, TS and TG1 (Fig. 5g). Similarly, treated ASPMΔ neurospheres responded correctly to growth stimuli (Fig. 5h). On the other hand, lentiviral-Cyclin E could not rescue the abnormally oriented ASPMΔ mitoses (Fig. 6a). These experiments establish dual mechanisms of ASPM autonomous regulation. Although CC progression is Cyclin E-dependent, mitotic cleavage orientation is Cyclin E-independent. Foremost, lentiviral-Cyclin E transduction was sufficient to confer partial rescue (~ 50%) of the enhanced ASPMΔ CC exit (Fig. 6b), suggesting that impaired CC reentry is the combined outcome of both Cyclin E-dependent CC lengthening and Cyclin E-independent abnormal mitotic orientation. Notably, ASPMΔ NPC orientation-independent tendency toward differentiative-neurogenic divisions measured by clonal pair-cell assay (Fig. 1j) was completely rescued in infected cells (Fig. 6c), further supporting the role of Cyclin E in NPC fate determination. Likewise, ASPMΔ premature exhaustion of the NPC reservoir (Fig. 1g) was brought to a standstill by lentiviral-Cyclin E transduction (Fig. 6d).
The delayed sequence of cortical development within ASPMΔ cortices (Supplementary Fig. 4a – e) was restored two days after lentiviral-Cyclin E transduction (Supplementary Fig. 4f). By E18.5, as embryonic corticogenesis ceases, even untreated ASPMΔ Cux1+ cells have reached their prospective destination in layers II-IV (Fig. 6e,f and Supplementary Fig. 4g). However, these ASPMΔ cortices displayed delayed astrogenesis. ASPMΔ astrocyte progenitors, RC2+ radial glia cells, showed disturbed fiber alignment (Fig. 6e). Correspondingly, fewer immature GFAP+ astrocytes were observed (Fig. 6f). Four days after lentiviral-Cyclin E transduction both deficiencies were restored.
The impaired G2/mitosis progression in ASPMΔ cortical germinal layers (Supplementary Fig. 8 and Supplementary Tables 3 and 4), which was further supported by a significantly increased number of PHH3+ cells in mutants (Supplementary Fig. 14a), also exhibits Cyclin E dependent and independent modes of ASPM regulation (Supplementary Fig. 14b – e). For further discussion into Cyclin A2 expression in ASPMΔ -NPC and the Cyclin A2/ASPM interaction, see Supplementary Fig. 14f – i.
ASPM protects Cyclin E from ubiquitination
Cyclin E abundance is regulated predominantly at the levels of gene transcription and ubiquitin-dependent proteolysis. The discrepancy between reduced Cyclin E protein levels (Fig. 3b) and increased mRNA expression in ASPMΔ NPC (Supplementary Fig. 13) points toward a post-transcriptional ubiquitin-dependent regulation. Accordingly, the high molecular weight smear detected only in ASPMΔ neurospheres treated with the proteasome inhibitor MG132 confirms that ASPM is necessary to protect Cyclin E from ubiquitination (Fig. 7a). To determine if administration of proteasome inhibitor could rescue the ASPMΔ abnormalities, settings for in utero introduction of MG132 into developing cortices were calibrated. Administration of MG132 into E15.25 forebrains effectively boosted ASPMΔ Cyclin E levels, especially the ubiquitin-susceptible42,43, ASPM-regulated P-Cyclin ET62 (Fig. 7b,c). Like lentiviral-Cyclin E transduction, MG132 treatment fully reverted the abnormally elongated ASPMΔ TC and TS (Fig. 7d,e). In addition, MG132 restored the abnormal excessive ASPMΔ NPC differentiative-neurogenic divisions (Fig. 7f), and completely reinstated normal NPC CC exit (Fig. 7g). Nevertheless, one must bear in mind that MG132 inhibition of ubiquitin-dependent protein degradation will stabilize many proteins. Thus, the restoration of proper cell cycle is likely to be an additive one through any number of cell cycle regulators.
The disparity between the partial in utero rescue of Q fraction by lentiviral-Cyclin E (Fig. 6b) and the complete rescue by MG132 (Fig. 7g) implies that MG132 treatment also affects Cyclin E independent- mitotic orientation dependent- increased ASPMΔ NPC differentiation. Although transduced lentiviral-Cyclin E cortices showed no indication of adjusted ASPMΔ mitotic orientation (Fig. 6a), the by far shorter MG132 treatment induced notable, yet statistically insignificant, modification toward normal orientation (Fig. 7h). As a result, differences between ASPMWT DMSO-treated and ASPMΔ MG132-treated mitoses became statistically insignificant. In utero MG132 administration most likely affects other converging signalling pathways including the previously shown genetic association between ASPM and β-catenin pathway44 (Supplementary Fig. 15). Ultimately, ASPMΔ exaggerated depletion of the NPC reservoir (Fig. 1g) was stalled by MG132 administration (Fig. 7i).
ASPM interacts with and stabilizes Cyclin E
Cyclin E and ASPM co-localize in several cellular compartments (Fig. 8a). Accordingly, ASPM was capable of co-immunoprecipitating the Cyclin E/Cdk2 complex (Fig. 8b,c). To examine the part taken by ASPM in Cyclin E turnover, degradation assays were employed. As previously shown43, co-expression of Cyclin E with either Fbw7 or Skp2 E3 ubiquitin ligases caused a substantial decrease in the level of Cyclin E protein (Fig. 8d). The decrease was partially averted by adding up ASPM (Fig. 8d). Correspondingly, overexpression of increasing amounts of ASPM led to a significant decrease of Fbw7 – and Skp2-mediated ubiquitination of Cyclin E (Fig. 8e,f). Next, the effect of ASPM on Cyclin E association with its ubiquitin E3-ligases was examined. Overexpression of increasing levels of ASPM exceedingly inhibited the association of Cyclin E with Fbw7 and Skp2 (Fig. 8e,f). ASPMΔ mice express the truncated 155 kDa ASPM product and an alternatively spliced variant of 205 kDa (Fig. 9a). Thus, the variants’ association with Cyclin E was compared with full-length ASPM protein product. All three ASPM isoforms were capable of co-IP with Cyclin E (Fig. 9a,b). However, the truncated and the alternatively spliced isoforms were substantially defective in eliminating Cyclin E degradation, as they were not capable of reducing its ubiquitination when expressed at comparable levels (Fig. 9c). Thus, full length ASPM is necessary to protect Cyclin E from ubiquitin-mediated degradation.
Discussion
Over the past 2.5 million years our ancestors tripled their brain size with a hallmark expansion of the cerebral cortex, primarily because of an increase in cell number. The majority of cortical neurons originate from proliferating NPC situated in the VZ and SVZ germinal compartments. Essentially, the evolutionary increase in cortical neurons reflects a growing potential of the NPC to undergo more cycles of divisions45,46. Accordingly, generation of neurons from NPC occurs in a precisely timed fashion. Most of early cortical VZ-NPC undergo symmetric proliferative division to self-renew and expend the progenitor pool. Later on, at mid-corticogenesis, VZ-NPC divide asymmetrically (neurogenic division) to self-renew and to generate either a neuron or an intermediate SVZ precursor. The concluding VZ divisions as well as SVZ-NPC undergo symmetric neurogenic division to generate two neurons3,16,18. However, comprehensive understanding of the mechanisms that regulate the switch from symmetric proliferative to asymmetric neurogenic to symmetric neurogenic cell division is lacking.
Data illustrated here confirm the link between CC duration and spatio-temporal control of the number of emerging neurons. While in faster cycling NPC, division mode appears to correlate with cleavage plane orientation independent of CC duration, the frequency of differentiative divisions increases only among NPC whose CC exceeds a threshold, in accordance with the G1-phase length hypothesis15,16. The present study provides surprising new insights to the process by which phase length affects NPC fate decisions. Though ASPMΔ NPC exhibit elongated CC, the lengthening could not be solely attributed to a G1 increase, as progression through S – and G2/M-phases were also delayed. Especially surprising was the finding that significant lengthening of the G1 occurred only in late (E16.5) ASPMΔ NPC. Although G1 duration of early ASPMΔ NPC was normal, comprehensive measurements established that the transition through the G1 – R-point was significantly postponed. The lack of reliable markers presented a challenge to distinguish between early and late G1-phases. However, the transfer of phosphorylated Cyclin E isoforms into the nucleus proved to be reliable indicative tool. This novel method corroborated the finding of delayed passage from the intrinsic and extrinsic signals-dependent early G1 to mitogen-independent late G1. Hence, in compliance with ASPM peaking during G1 (ref. 47), ASPMΔ G1-NPC linger uncommitted throughout a longer episode of susceptibility to mitogenic differentiation signals (Fig. 10).
Proper CC progression depends on strict management of Cyclin E/Cdk2 levels and activities. Correspondingly, Cyclin E abundance oscillates during normal CC attaining a maximum level of expression in late G1 (ref. 39). However, studies have demonstrated that Cyclin E also controls mitotic progression (see references in Supplementary Fig. 14), and S-phase progression and completion in a pRB/E2F independent manner48,49. Accordingly, it has been demonstrated that the expansion of the NPC reservoir correlates with the time spent by the cells during S-pahse17. In addition to gene transcription, Cyclin E abundance is controlled at the level of ubiquitin-dependent proteolysis. Various modes of regulations direct Cyclin E degradation including ubiquitination by at least two E3-ligases (Fbw7 and Skp2) associated with phosphorylation on at least four different sites, T62, S372, T380 and S384, by at least two kinases (Gsk3 and Cdk2)36,37,40,42,43,50–52. Cyclin E contains two Cdc4-phosphodegron motifs that direct Fbw7 binding and stimulate Cyclin E ubiquitination and degradation53. The T380-containing degron is regarded as the dominant Cyclin E degradation signal making more extensive high-affinity contacts with Fbw7, whereas the T62 site is a weaker sub-optimal degron40,42,43,50,54,55. Therefore, the T380-containing degron has been considered more physiologically significant. Thus, the difference of P-CycET380 signal intensity between WT and ASPMΔ NPC is expected to be bigger than P-CycET62. However, previous studies have shown that ablation of the T380 degron did not fully stabilize Cyclin E56. Also, mutation of T62 reduced the extent of T380 phosphorylation43, suggesting an indirect effect of the T62 degron on Cyclin E degradation through the T380 degron. Otherwise, the two-phosphodegron motifs might function as independent redundant pathway- or tissue-specific constituents of Cyclin E degradation. A previously unknown pattern of sequential Cyclin E phosphorylation, as NPC progress along G1 – into S-phase, is demonstrated here (Fig. 3j–m). Initially, at mid G1, residue T62 is predominantly phosphorylated followed by added phosphorylation on T380. Accordingly, we propose that in addition to independent spatial function, the two-phosphodegron motifs might also exhibit independent temporal function. As NPC progress along the G1-phase, Cyclin E is first phosphorylated at T62 subjecting it to ubiquitination and degradation. By the time T380 is being phosphorylated, most of Cyclin E has already been degraded. Hence, a comparison between P-CycET380 and P-CycET62 signal intensities in WT – and ASPMΔ -NPC showed similar decrease (Fig. 3g). Cyclin E phosphorylation on T380 does not require Cdk2 (ref. 40), suggesting that Cdk2 affects Cyclin E turnover primarily via T62. Thus, T62 being the earliest phosphorylated residue with a sustained prominence throughout the G1 to S interval is reminiscent of Cdk2 being Cyclin E immediate partner.
Clear partitioning of ASPM functions into two autonomous mechanisms was achieved by in utero lentiviral-Cyclin E transduction experiments. Cyclin E-dependency was established by an absolute reinstatement of the aberrant mutant CC. In contrast, mitotic cleavage regulation proved to be Cyclin E-independent due to ineffective rescue of orientation irregularity. On the whole, Cyclin E partial rescue of the ASPMΔ increased rate of differentiation corroborates that ASPM regulation of NPC fate is a combination of both Cyclin E-dependent CC duration, and Cyclin E-independent cleavage plane orientation (Fig. 10). Interestingly, lentiviral-Cyclin E transduction into heterozygous telencephalons resulted in an insignificantly increased cortical lobe length at the anteromedial-posterolateral axis (Fig. 5e,f) in correlation with no apparent acceleration of the CC and its various phases (Fig. 5g). Moreover, lentiviral-Cyclin E transduced WT neurospheres were not hypersensitive to proliferation stimuli (Fig. 5h). Consequently, the NPC reservoir of lentiviral-Cyclin E transduced WT cortices declined in the same pace as control (Fig. 6d). On the other hand, lentiviral-Cyclin E transduced ASPMΔ NPC displayed significantly shorten CC, primarily due to shorter TG1, even in comparison to WT. Furthermore, stimulated lentiviral-Cyclin E transduced ASPMΔ neurospheres grew faster then WT. The Cyclin D-Cyclin E-Rb-E2F pathway functions as a bistable switch regulating the R-point upon the cell commitment to proliferation independently of external stimulation. The nature of a bistable switch mechanism is based on high-threshold, low-maintenance characteristics. First, high threshold of stimulation is established to guarantee preconditions for fully implemented proliferation followed by a low-maintenance requirements to ensure that the cycle is completed once initiated, even in the absence of continuous stimulation. Once turned ON by adequate stimulation, E2F memorize and sustain this ON state independently of constant stimulation57. At the beginning of G1, E2F is bound to and repressed by RB. With sufficient stimulation, activity of Cyclin D/Cdk4,6 is induced to launch RB phosphorylation and to relieve its repression of E2F. E2F activates the transcription of Cyclin E, which complexes with Cdk2 to further phosphorylate and completely remove RB repression, establishing a positive-feedback loop, which is a hallmark of a bistable switch. Hence, the stably balanced WT R-point is not affected by addition of Cyclin E due to several positive feedback circuits (also including the mutual inhibition between Cyclin E/Cdk2 and p27Kip1 loop). ASPMΔ R-point, on the other hand, is unstable and therefore responds more erratically to external stimulations such as the lentiviral-Cyclin E transduction.
The absence of change in the mode of division after lentiviral-Cyclin E transduction into WT-NPC (Fig. 6b,c) stands at odds with previously published results22. A number of procedural variations between the two assays might result in the discrepancy. Namely, the electroporation method used by Pilaz et al. selectively targets S –, G2 –, and M-phase VZ-NPC with a very low efficiency in G1 cells. This is not the case with lentiviral infection that targets all cells, irrespectively of their cycling status. Nonetheless, while Pilaz et al. demonstrated that cumulative S phase labelling was inappropriately used for measuring CC kinetics in synchronous electroporated population21, lentiviral mediated gene transfer yielded > 99% overexpression efficiency (Fig. 5c), and therefore is compatible with any S-phase labelling technique.
Since all the defined microcephaly proteins reside at centrosomes or spindle poles, the predominant model for the etiology of microcephaly has emphasized on spindle organization, stability, and orientation as well as centrosome function, assembly, stability, maturation and amplification58,59. Therefore, the most studied basis for microcephaly involves disrupted spindle orientation and altered symmetric division of NPC, leading to depletion of the progenitor pool and increased neuronal differentiation28,59,60. However, current studies have identified more diverse cellular grounds for microcephaly including, DNA damage response and repair60–63, transcriptional regulation61,63,64, centriole biogenesis65, mitotic arrest58,59,66, cell death59,65–67, ciliogenes58 and lipid transport68. Our study adds the ubiquitin-Cyclin E-Rb-E2F as an additional cellular pathway that plays a major role in the etiology of microcephaly.
Methods
Mouse breeding
Mice were maintained in pathogen-free conditions. All surgical intervention and subsequent care and treatment were in strict accordance with the PHS Policy on Humane Care and Use of Laboratory Animals and the University of Utah IACUC guidelines.
Tissue processing
Brains of E16.5-E17.5, P4 and 8–10-weeks-old mice were removed from the skull and fixed by immersion in 4% paraformaldehyde (PFA) for 3.5 h at 4 °C. Younger then E16.5 embryos were decapitated and the entire heads were fixed. Samples were washed three times in PBS before cryoprotected in 10%, 20 and 30% (v/v) sucrose gradient in PBS at 4 °C and embedded in OCT tissue-freezing medium (Tissue-Tek). Tails (postnatal) or trunk (embryo) samples were collected for genotyping.
Immunofluorescence
Sections were permeabilized and blocked in PBST (1 × PBS, 0.5% (v/v) Triton X-100) containing 10% NGS for 1 h at 4 °C. Primary Abs were incubated overnight at 4 °C in PBST with 5% NGS and secondary Abs were incubated in the same buffer for 1–2 h at room temperature (RT). Nuclei were stained with DAPI. Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) was performed using the in situ cell death detection kit (Roche BioSciences). Slides were mounted in Flouromount-G anti-fade reagent (SouthernBiotech). For pulse-chase experiments 5-Bromo-2’-deoxyuridine (BrdU dissolved in 0.007 N NaOH, 0.9% NaCl), 5-Iodo-2′-deoxyuridine (IdU dissolved in 0.014 N NaOH, 0.9% NaCl) and 5-Chloro-2’-deoxyuridine (ChdU dissolved in PBS) (Sigma-Aldrich) were injected intraperitoneally (50µgg−1) and chased for times specified. Sections were air dry for 1 h at RT, followed by 20 min incubation in acetone at 4 °C and air dry again for 1 h at RT. Next, the sections were washed in PBST and antigen was unmasked by boiling for 13 min in 10 mM Citrate buffer (pH 6). Once solution had cooled down to RT, sections were washed in PBST and treated for 45 min with 2 N HCl/0.1% Triton X-100 in PBS at 37 °C. After extensive washes, the sections were blocked and incubated with the respected Abs as before.
In case of double staining with one Abs being an S-phase tracer (IdU/BrdU/ ChdU), after cooling down from boiling in Citrate buffer, sections were blocked and incubated overnight with the non-tracer Abs at 4 °C. Following incubation with the appropriate secondary Abs and adequate washing, sections were postfix with 8% PFA in PBS for 20 min at 4 °C before proceeding to the HCl treatment as described above.
For NPC and HEK293T immunostaining, cells were fixed in ice-cold 4% PFA solution for 30 min followed by ice-cold methanol for 5 min before successively treated with primary and secondary Abs. For Abs and dilutions, see Supplementary Table 6.
Determination of basal mitoses cleavage plane orientation
SYTOX (Molecular Probes)-stained chromosomes in metaphase and anaphase/telophase were sorted according to the angle of the cleavage plane relative to the ventricle surface (VS). Cleavage plane was defined as horizontal (0–30°), that is, the mitotic spindle aligned perpendicular to the VS, oblique (30–60°), or vertical (60–90°), that is, mitotic spindle aligned parallel to the apical-basal axis of the VS. To simultaneously identify chromosomes and the entire framework of the basal mitoses sections were co-stained for Alexa Flour 546 phalloidin (Invitrogen).
In vitro culture of neural progenitors
NPC isolation. E12.5 telencephalic lobes were dissected and digested for 30 min at RT with 500 U ml−1 papain (Worthington) and 100 U ml−1 DNase I (Fermentas) in dissociation medium (DMEM/F12 supplemented with sodium pyruvate, non-essential amino-acids, l-glutamine (GibcoBRL) and 5 mM N-acetylcysteine (Sigma-Aldrich)) with rocking. Enzymatic digestion was stop by addition of DMEM/F12 medium. Tissue was disintegrated into a single cell suspension by gentle pipetting. Cells were passed though a 45 µm nylon screen.
Neurospheres
Cells were seeded at clonal density (5,000 cells cm−2 1.3 cells µl−1) onto ultra low attachment multiwell plates (costar) in Neurosphere medium (DMEM/F12 supplemented with sodium pyruvate, l-glutamine, penicillin/streptomycin, N2, B-27, 1 mM N-acetyl-cysteine, 15% chick embryo extract (Invitrogen) and 20 ng ml−1 human basic fibroblast growth factor (bFGF; R&D Systems) was added daily). Neurospheres were incubated in the presence of 20 ng ml−1 epidermal growth factor (EGF) and 20 ng ml−1 insulin-like growth factor (IGF-I) (R&D Systems) to stimulate proliferation. Diameters of single neurospheres were measured after 7 days of culture. Seven day-old primary neurospheres were triturated to yield single cell suspensions then grown for 7 additional days to assess sizes of secondary neurospheres. Images were acquired using Leica EL6000 microscope and captured with Digital Photo Professional version 3.3.1 software (Canon Inc.).
Pair-cell analysis
Single cells were plated at clonal density (30–40 cells well−1) into poly-l-lysinecoated 16-well glass slide (Nunc) in serum-free medium (DMEM with l-glutamine, sodium pyruvate, B-27, N2, 1 mM N-acetylcysteine and 10 ng ml−1 bFGF). Pair-cells were identified at 24 h, washed, fixed and stained for Pax6 and Tuj1. For secondary pair-cell analysis, freshly isolated single cells were plated into 60 mm poly-l-lysine-coated plates in Neurospheres medium for 24 or 48 h, before applying enzymatic detachment (papain), three washes and re-plating for additional 24 or 48 h as describe. P-P pairs were assessed as being Pax6+/Pax6+ and TuJ1−/TuJ1−. N-N pairs were assessed as being Pax6−/Pax6− and TuJ1+/TuJ1+. P-N pairs were assessed as being Pax6+/TuJ1− and Pax6−/TuJ1+. For Abs and dilutions, see Supplementary Table 6.
In utero lentiviral transduction
An E14.5 pregnant dams were anesthetized with 2.5% Avertin (1.8 cm3 g−1, ip injection). The anesthetized mice were placed on a 37 °C heating pad (FHC, Bowdoin, ME) and the depth of anesthesia was evaluated by examination of pinch withdrawal, eyelid reflex, vibrissae movements and respiration rate. Abdominal hair was removed and skin surface was disinfected with 10% povidone-iodine (Vetone) and sterilized with 70% ethanol. Embryos were taken out of the peritoneal cavity through a 1 cm midline incision and attentively kept moist while out of the peritoneum. 1 µl of lentiviral solution, diluted 1:100 in 0.05% Fast Green (SIGMA) in HBSS, was administered into the embryonic lateral ventricles through the uterine wall using a Hamilton syringe (#95) and a 34 gauge beveled needle (NF34BV, WPI) adjusted with a modified gasket adaptor (NF GSK-5, WPI). The uterus was placed back into the peritoneal cavity and lavaged with sterile PBS. Abdominal musculature and skin were closed using Reflex 9 stainless steel wound clips. Dams were placed on their back in the cage at 37 °C and wounds were administrated with 0.5% Marcaine.
In utero proteasome inhibitor administration
E15.25 pregnant dams were anesthetized and treated as before. MG132 (50 mM, stock) was diluted to 5 µM with 0.05% Fast Green in HBSS. Similarly, DMSO was diluted 1:10,000 with 0.05% Fast Green in HBSS. Embryos lateral ventricles were injected with 0.4 µl solution. All procedures were terminated within 18 h. These carefully calibrated setting enabled analysis without apparent increased cell death.
Transcription activity of endogenous E2F
Freshly isolated E12.5 telecephalic cells maintained in neurosphere medium were allowed to attach to poly-l-lysine coated plates for 8 h before transfected using lipofectamine (invitrogen) according to manufacturer’s directions. The Luciferase and Renilla assays were performed 36 h after transfection (Promega) according to manufacturer’s directions and measured on a luminometer. The E2F transcription reporter, 6xE2F–luciferase, construct contains the following sequence 5′-TTTCGCGCTTAA′TTTCGCGCC AAA′CG CGTGCTAGC′TTTCGCGCCAAA′TTTCGCGCTTAA′TTTCGCGGC AAA′TATATAAT-3′ inserted into pGL3 vector (Promega) in front of the luciferase coding sequence. It includes the following six E2F binding sites in tandem: 12mer from position −68 of the E2AE1 gene in the adenovirus 2 genome, position −10 of the mouse DHFR gene, second E2AE1 bonding site, second DHFR binding site, third E2AE1, and position −46 of the mouse E2F1 gene before TATA box. CMV-Renilla construct was used for normalizing the efficiency of the transfection.
Kinase assays
E12.5 telencephalic lobe extracts were incubated ON at 4°C with saturating concentrations of Cyclin E, Cdk2, or Cyclin D1 Abs. Immune complexes were collected by incubation with Dynabeads Protein G (invitrogen) for 1 h at 4 °C, and equilibrated on kinase buffer (50 mM TrisHCl pH7.5, 20 mM EGTA, 10 mM MgCl2, 1 mM DTT, 1 mM β-glycerolphosphate). For the kinase assays, 10 ml of kinase reaction mixture (0.4 mM ATP pH 7.5, and 10 mCi [γ-32 P]ATP (Amersham Pharmacia)) in kinase buffer containing substrate (2.5 µg of histone-H1 (Sigma-Aldrich) for Cyclin E and Cdk2, and 0.2 µg of soluble GST-pRb fusion protein (Santa Cruz Biotechnology) for Cyclin D1, was added to the immunoprecipitated complexes. After 30 min of incubation at 37 °C, reactions were stopped by adding 5 µl of Laemmli loading SDS buffer and heating at 100 °C for 10 min. Labelled proteins were resolved by 15% SDS-PAGE. Gels were incubated twice in 20% methanol; 10% glycerol solution before dried on 3 mm paper at 50 °C with vacuum. Images were acquired on Typhoon TRIO + imaging system (Amersham). For Abs and dilutions, see Supplementary Table 6.
Semi quantitative RT-PCR analysis
Isolated total RNA (Tri-Reagent MRC) was reverse transcribed using First Strand cDNA Synthesis kit (Fermentas). For primer sequences, see Supplementary Table 5.
Plasmids
To generate HA-hASPM expression plasmid, the human ASPM coding region was amplified by PCR from total human fetal brain cDNA (BioChain Institute, Inc.) and cloned into HA containing plasmid under CAG promoter. To generate hCyclin E1, myc-hSKP2 and myc-hFBW7 expression plasmids the human respective coding regions were amplified by RT-PCR from HEK293T total RNA extracts and cloned into non-tagged or myc containing plasmids, respectively under CAG promoters. The pcDNA3-myc-wt-mCycE, pcDNA3-myc-mCycET62G, pcDNA3-myc-mCycET380G plasmids were obtained from Genscript.
Coimmunoprecipitation
Lysates of MG132 treated neurospheres (20 µM, Sigma-Aldrich) or HEK293T cells transiently expressing HA-tagged respective proteins were incubated overnight at 4 °C with anti-HA or anti-Ub Abs, respectively, cross-linked (dimethyl pimelimidate) beforehand to Dynabeads Protein G (invitrogen). Adequately washed bound material was subsequently eluted by 50 mM Glycine (pH 2.8) and boiled for 10 min. Standard western blotting procedure was used to analyse the immunoprecipitants and input samples. For Abs and dilutions, see Supplementary Table 6. Uncropped images of blots are shown in Supplementary Figs 16 and 17. Post-blot images are shown in Supplementary Fig. 18.
Statistical analysis and microscopy
All cell counting, tilt classification, dimension and immunofluorescence intensity measures were made without the experimenter being aware of the subject genotype. Images were acquired using Zeiss Axiovert 200 M microscope and captured with Slidebook software (Intelligent Imaging Innovations). Analyses were performed on randomly collected 4–10 non-consecutive serial coronal sections taken from approximately the mid-hemisphere level corresponding to the primordial primary somatosensory cortex. Counts were performed manually in a fixed area of 500 µm in its medial-lateral dimension and 6 µm (corresponding to section thickness) in its rostral-caudal dimension for all the different applications. Results were averaged per animal. No statistical method was used to predetermine sample size since there were no attrition or exclusion of samples. To distinguish between independent data points, experiments were biologically repeated three to four times from animals of at least two different litters. Acquired data was normally distributed and variation within each experimental group was similar. Statistical tests were used to compare data and their P values are indicated in the figure legends. Data were analysed with Excel software using Student’s t-test (Microsoft). P values (2-tailed) <0.05 were considered statistically significant. For multiple group analyses, a two-way ANOVA (JMP 8 software) or χ2 -square (Excel software) were applied.
Supplementary Material
Acknowledgments
We are grateful to Lara S. Carroll for her constructive advices, critical scientific inputs, analysis suggestions, stimulating discussions and for editing the manuscript. We thank Yuanyuan Wu, Hideaki Tomita and Sen Wu for technical advices. We also thank Kay Higgins and Petr Tvrdik for encouragement and logistical support toward the project.
Footnotes
Author contributions
A.P. conceived the study, created the ASPMΔ mouse line, designed and performed the experiments, analysed and interpreted the data, and wrote the manuscript. M.C. provided most of the resources.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Competing financial interests: The authors declare no competing financial interests.
References
- 1.Bond J, et al. ASPM is a major determinant of cerebral cortical size. Nat. Genet. 2002;32:316–320. doi: 10.1038/ng995. [DOI] [PubMed] [Google Scholar]
- 2.Bond J, et al. Protein-truncating mutations in ASPM cause variable reduction in brain size. Am. J. Hum. Genet. 2003;73:1170–1177. doi: 10.1086/379085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Taverna E, Gotz M, Huttner WB. The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex. Annu. Rev. Cell. Dev. Biol. 2014;30:465–502. doi: 10.1146/annurev-cellbio-101011-155801. [DOI] [PubMed] [Google Scholar]
- 4.Arcila ML, et al. Novel primate miRNAs coevolved with ancient target genes in germinal zone-specific expression patterns. Neuron. 2014;81:1255–1262. doi: 10.1016/j.neuron.2014.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gilbert SL, Dobyns WB, Lahn BT. Genetic links between brain development and brain evolution. Nat. Rev. Genet. 2005;6:581–590. doi: 10.1038/nrg1634. [DOI] [PubMed] [Google Scholar]
- 6.Ponting C, Jackson AP. Evolution of primary microcephaly genes and the enlargement of primate brains. Curr. Opin. Genet. Dev. 2005;15:241–248. doi: 10.1016/j.gde.2005.04.009. [DOI] [PubMed] [Google Scholar]
- 7.Rujano MA, Sanchez-Pulido L, Pennetier C, le Dez G, Basto R. The microcephaly protein Asp regulates neuroepithelium morphogenesis by controlling the spatial distribution of myosin II. Nat. Cell. Biol. 2013;15:1294–1306. doi: 10.1038/ncb2858. [DOI] [PubMed] [Google Scholar]
- 8.Pulvers JN, et al. Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline. Proc. Natl Acad. Sci. USA. 2010;107:16595–16600. doi: 10.1073/pnas.1010494107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.van der Voet M, et al. NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5/GPR/Galpha. Nat. Cell. Biol. 2009;11:269–277. doi: 10.1038/ncb1834. [DOI] [PubMed] [Google Scholar]
- 10.Fish JL, Kosodo Y, Enard W, Paabo S, Huttner WB. Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. Proc. Natl Acad. Sci. USA. 2006;103:10438–10443. doi: 10.1073/pnas.0604066103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Imai F, et al. Inactivation of aPKClambda results in the loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in mouse neocortex. Development. 2006;133:1735–1744. doi: 10.1242/dev.02330. [DOI] [PubMed] [Google Scholar]
- 12.Konno D, et al. Neuroepithelial progenitors undergo LGN-dependent planar divisions to maintain self-renewability during mammalian neurogenesis. Nat. Cell. Biol. 2008;10:93–101. doi: 10.1038/ncb1673. [DOI] [PubMed] [Google Scholar]
- 13.Delaunay D, Cortay V, Patti D, Knoblauch K, Dehay C. Mitotic spindle asymmetry: a Wnt/PCP-regulated mechanism generating asymmetrical division in cortical precursors. Cell Rep. 2014;6:400–414. doi: 10.1016/j.celrep.2013.12.026. [DOI] [PubMed] [Google Scholar]
- 14.Delaunay D, Robini MC, Dehay C. Mitotic spindle asymmetry in rodents and primates: 2D vs. 3D measurement methodologies. Front. Cell Neurosci. 2014;9:33. doi: 10.3389/fncel.2015.00033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dehay C, Kennedy H. Cell-cycle control and cortical development. Nat. Rev. Neurosci. 2007;8:438–450. doi: 10.1038/nrn2097. [DOI] [PubMed] [Google Scholar]
- 16.Gotz M, Huttner WB. The cell biology of neurogenesis. Nat. Rev. Mol. Cell Biol. 2005;6:777–788. doi: 10.1038/nrm1739. [DOI] [PubMed] [Google Scholar]
- 17.Arai Y, et al. Neural stem and progenitor cells shorten S-phase on commitment to neuron production. Nat. Commun. 2011;2:154. doi: 10.1038/ncomms1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Nowakowski RS, Hayes NL. Developmental Biology. Kluwer Academic/Plenum Publishers; 2005. pp. 21–39. [Google Scholar]
- 19.Calegari F, Haubensak W, Haffner C, Huttner WB. Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J. Neurosci. 2005;25:6533–6538. doi: 10.1523/JNEUROSCI.0778-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Calegari F, Huttner WB. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J. Cell. Sci. 2003;116:4947–4955. doi: 10.1242/jcs.00825. [DOI] [PubMed] [Google Scholar]
- 21.Lange C, Huttner WB, Calegari F. Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell. 2009;5:320–331. doi: 10.1016/j.stem.2009.05.026. [DOI] [PubMed] [Google Scholar]
- 22.Pilaz LJ, et al. Forced G1-phase reduction alters mode of division, neuron number, and laminar phenotype in the cerebral cortex. Proc. Natl Acad. Sci. USA. 2009;106:21924–21929. doi: 10.1073/pnas.0909894106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nonaka-Kinoshita M, et al. Regulation of cerebral cortex size and folding by expansion of basal progenitors. EMBO J. 2013;32:1817–1828. doi: 10.1038/emboj.2013.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Artegiani B, Lindemann D, Calegari F. Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain. J. Exp. Med. 2011;208:937–948. doi: 10.1084/jem.20102167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Stead E, et al. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene. 2002;21:8320–8333. doi: 10.1038/sj.onc.1206015. [DOI] [PubMed] [Google Scholar]
- 26.Fluckiger AC, et al. Cell cycle features of primate embryonic stem cells. Stem Cells. 2006;24:547–556. doi: 10.1634/stemcells.2005-0194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Haydar TF, Ang E, Jr, Rakic P. Mitotic spindle rotation and mode of cell division in the developing telencephalon. Proc. Natl Acad. Sci. USA. 2003;100:2890–2895. doi: 10.1073/pnas.0437969100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Buchman JJ, Tsai LH. Spindle regulation in neural precursors of flies and mammals. Nat. Rev. Neurosci. 2007;8:89–100. doi: 10.1038/nrn2058. [DOI] [PubMed] [Google Scholar]
- 29.Takahashi T, Nowakowski RS, Caviness VS., Jr The leaving or Q fraction of the murine cerebral proliferative epithelium: a general model of neocortical neuronogenesis. J. Neurosci. 1996;16:6183–6196. doi: 10.1523/JNEUROSCI.16-19-06183.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lukaszewicz A, et al. G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex. Neuron. 2005;47:353–364. doi: 10.1016/j.neuron.2005.06.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Glickstein SB, Monaghan JA, Koeller HB, Jones TK, Ross ME. Cyclin D2 is critical for intermediate progenitor cell proliferation in the embryonic cortex. J. Neurosci. 2009;29:9614–9624. doi: 10.1523/JNEUROSCI.2284-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Paik JH, et al. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell. 2009;5:540–553. doi: 10.1016/j.stem.2009.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Horvath S, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl Acad. Sci. USA. 2006;103:17402–17407. doi: 10.1073/pnas.0608396103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tarui T, et al. Overexpression of p27 Kip 1, probability of cell cycle exit, and laminar destination of neocortical neurons. Cereb. Cortex. 2005;15:1343–1355. doi: 10.1093/cercor/bhi017. [DOI] [PubMed] [Google Scholar]
- 35.Orford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genet. 2008;9:115–128. doi: 10.1038/nrg2269. [DOI] [PubMed] [Google Scholar]
- 36.Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 1995;15:2612–2624. doi: 10.1128/mcb.15.5.2612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ekholm SV, Zickert P, Reed SI, Zetterberg A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol. Cell. Biol. 2001;21:3256–3265. doi: 10.1128/MCB.21.9.3256-3265.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Matsumoto Y, Maller JL. A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science. 2004;306:885–888. doi: 10.1126/science.1103544. [DOI] [PubMed] [Google Scholar]
- 39.Koff A, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 1992;257:1689–1694. doi: 10.1126/science.1388288. [DOI] [PubMed] [Google Scholar]
- 40.Welcker M, et al. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell. 2003;12:381–392. doi: 10.1016/s1097-2765(03)00287-9. [DOI] [PubMed] [Google Scholar]
- 41.Zarkowska T, Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 1997;272:12738–12746. doi: 10.1074/jbc.272.19.12738. [DOI] [PubMed] [Google Scholar]
- 42.Koepp DM, et al. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 2001;294:173–177. doi: 10.1126/science.1065203. [DOI] [PubMed] [Google Scholar]
- 43.Ye X, et al. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 2004;279:50110–50119. doi: 10.1074/jbc.M409226200. [DOI] [PubMed] [Google Scholar]
- 44.Buchman JJ, Durak O, Tsai LH. ASPM regulates Wnt signaling pathway activity in the developing brain. Genes Dev. 2011;25:1909–1914. doi: 10.1101/gad.16830211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lui JH, Hansen DV, Kriegstein AR. Development and evolution of the human neocortex. Cell. 2011;146:18–36. doi: 10.1016/j.cell.2011.06.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nat. Rev. Neurosci. 2009;10:724–735. doi: 10.1038/nrn2719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Singhmar P, Kumar A. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation. PLoS ONE. 2011;6:e20397. doi: 10.1371/journal.pone.0020397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lukas J, et al. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 1997;11:1479–1492. doi: 10.1101/gad.11.11.1479. [DOI] [PubMed] [Google Scholar]
- 49.Knoblich JA, et al. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell. 1994;77:107–120. doi: 10.1016/0092-8674(94)90239-9. [DOI] [PubMed] [Google Scholar]
- 50.Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer. 2008;8:83–93. doi: 10.1038/nrc2290. [DOI] [PubMed] [Google Scholar]
- 51.Grim JE, et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J. Cell Biol. 2008;181:913–920. doi: 10.1083/jcb.200802076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hwang HC, Clurman BE. Cyclin E in normal and neoplastic cell cycles. Oncogene. 2005;24:2776–2786. doi: 10.1038/sj.onc.1208613. [DOI] [PubMed] [Google Scholar]
- 53.Orlicky S, Tang X, Willems A, Tyers M, Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell. 2003;112:243–256. doi: 10.1016/s0092-8674(03)00034-5. [DOI] [PubMed] [Google Scholar]
- 54.Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 1996;10:1979–1990. doi: 10.1101/gad.10.16.1979. [DOI] [PubMed] [Google Scholar]
- 55.Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell. 2007;26:131–143. doi: 10.1016/j.molcel.2007.02.022. [DOI] [PubMed] [Google Scholar]
- 56.Minella AC, et al. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 2008;22:1677–1689. doi: 10.1101/gad.1650208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Yao G, Lee TJ, Mori S, Nevins JR, You L. A bistable Rb-E2F switch underlies the restriction point. Nat. Cell. Biol. 2008;10:476–482. doi: 10.1038/ncb1711. [DOI] [PubMed] [Google Scholar]
- 58.Megraw TL, Sharkey JT, Nowakowski RS. Cdk5rap2 exposes the centrosomal root of microcephaly syndromes. Trends. Cell. Biol. 2011;21:470–480. doi: 10.1016/j.tcb.2011.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Lizarraga SB, et al. Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. Development. 2010;137:1907–1917. doi: 10.1242/dev.040410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Feng Y, Walsh CA. Mitotic spindle regulation by Nde1 controls cerebral cortical size. Neuron. 2004;44:279–293. doi: 10.1016/j.neuron.2004.09.023. [DOI] [PubMed] [Google Scholar]
- 61.Yang SZ, Lin FT, Lin WC. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis. EMBO. Rep. 2008;9:907–915. doi: 10.1038/embor.2008.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Shen J, et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat. Genet. 2010;42:245–249. doi: 10.1038/ng.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Alderton GK, et al. Regulation of mitotic entry by microcephalin and its overlap with ATR signalling. Nat. Cell. Biol. 2006;8:725–733. doi: 10.1038/ncb1431. [DOI] [PubMed] [Google Scholar]
- 64.Yang YJ, et al. Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation. Cell. 2012;151:1097–1112. doi: 10.1016/j.cell.2012.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Marthiens V, et al. Centrosome amplification causes microcephaly. Nat. Cell. Biol. 2013;15:731–740. doi: 10.1038/ncb2746. [DOI] [PubMed] [Google Scholar]
- 66.Chen JF, et al. Microcephaly disease gene Wdr62 regulates mitotic progression of embryonic neural stem cells and brain size. Nat. Commun. 2014;5:3885. doi: 10.1038/ncomms4885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kim S, et al. The apical complex couples cell fate and cell survival to cerebral cortical development. Neuron. 2010;66:69–84. doi: 10.1016/j.neuron.2010.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Betsholtz C. Lipid transport and human brain development. Nat. Genet. 2015;47:699–701. doi: 10.1038/ng.3348. [DOI] [PubMed] [Google Scholar]
- 69.Wang XD, Rosales JL, Magliocco A, Gnanakumar R, Lee KY. Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain. Oncogene. 2003;22:769–774. doi: 10.1038/sj.onc.1206166. [DOI] [PubMed] [Google Scholar]
- 70.Paramasivam M, Chang YJ, LoTurco JJ. ASPM and citron kinase co-localize to the midbody ring during cytokinesis. Cell Cycle. 2007;6:1605–1612. doi: 10.4161/cc.6.13.4356. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.